James M. Inhofe bought BMY

February 1, 2017 · STOCK Act disclosure

Senator James M. Inhofe (Republican-OK) bought Bristol-Myers Squibb Company, a stock transaction, valued at $15,001 - $50,000. The trade took place on February 1, 2017 and was disclosed on March 2, 2017 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.